Abstract:【Abstract】Objective To explore expression of serum Von HippelLindau (VHL), hypoxiainducible factor1 (HIF1α) and hypoxiainducible factor2 (HIF2α) in renal carcinoma patients and their correlation with prognosis. Methods Eightytwo patients with renal carcinoma admitted to the hospital from March 2015 to March 2016 were enrolled as renal carcinoma group. 51 healthy people were enrolled as control group. The enzymelinked immunosorbent assay (ELISA) was performed to determine levels of VHL, HIF1α and HIF2α in both groups. Results The level of VHL in renal carcinoma group was significantly lower than that in control group, while levels of HIF1α and HIF2α were significantly higher than those in control group (P<005). The level of VHL in renal carcinoma patients at stage Ⅰ/Ⅱ and Ⅲ after surgery was higher than that before surgery. VHL level in patients at stage Ⅰ/Ⅱ was higher than that at stage Ⅲ (P<005). The levels of HIF1α and HIF2α in renal carcinoma patients at stage Ⅰ/Ⅱ and Ⅲ after surgery were lower than those before surgery. And the above indexes in patients at stage Ⅰ/Ⅱ were lower than those at stage Ⅲ (P<005). The expression levels of serum VHL, HIF1α and HIF2α in renal carcinoma patients were not related with age or gender (P>005), while related with lesion diameter, lymph node metastasis, pathological grading and TNM staging (P<005). The 3year survival rate of renal cancer carcinoma was not related with age or gender (P>005). The 3year survival rate of patients with VHL high expression was significantly higher than that with VHL low expression (8333% vs 6000%) (P<005), while 3year survival rates of patients with high expression of HIF1α and HIF2α were significantly lower than those with low expression of HIF1α, HIF2α (5098%, 5217% vs 7742%, 8055%) (P<005). The low expression of serum VHL, high expression of serum HIF1α and HIF1α were independent risk factors of postoperative kidney failure in renal carcinoma patients. The level of VHL was negatively correlated with occurrence of renal carcinoma, while HIF1α and HIF2α were positively correlated with it (P<005). The optimal cutoff values of serum VHL, HIF1α and HIF2α for predicting renal carcinoma patients were 37978, 771 and 095, respectively. AUC of combination prediction of the three was greater than that of VHL (Z=8268, P<005), HIF1α (Z=8268, P<005) and HIF2α (Z=8268, P<005). Conclusion Serum VHL, HIF1α and HIF2α can be applied as important indexes to determine occurrence and development of renal carcinoma. They can not only affect shortterm survival rate of patients, but also are of good prediction value for prognosis of renal carcinoma patients. They can be applied as molecular markers of prognosis prediction. The combination application of the three can improve prediction ability of prognosis.